Compliance of drug price display rule at 55%, Dewan Rakyat told
The remaining 45% had incomplete or inaccessible price displays, he added.
ALSO READ: Drug price display order gazetted, to come into effect May 1
"These findings indicate the need for continued monitoring, guidance sessions and phased enforcement for non-compliant premises," he said during Minister's Question Time in the Dewan Rakyat on Tuesday (Aug 12).
To ensure greater transparency and fairness in private healthcare pharmacy services, Lukanisman said the Health Ministry plans to conduct a comprehensive evaluation from September.
"This aims to assess the impact of the drug pricing policy and guide improvements in the system.
"It will inform (these) improvements to ensure transparency and fairness in private healthcare pharmacy services," he added.
ALSO READ: Medicine price display rule to proceed on Aug 1, says Health Minister
The display of drug prices, which came into effect on May 1 under the Price Control and Anti-Profiteering (Marking of Prices for Drugs) Order 2025, is part of the government's efforts to enhance public access to drug price information.
This initiative seeks to ensure competitive pricing and informed consumer choices.
From Aug 1, the ministry began inspections and monitoring, issuing warnings for non-compliance, with full enforcement and fines scheduled to commence on Jan 1.
The phased approach aims to give private healthcare providers, including clinics, hospitals and community pharmacies, time to adjust and comply with the new regulations.
The initiative faced some resistance from non-governmental organisations and medical associations, particularly concerning the regulation of consultation fees, which have not been reviewed for 30 years.
ALSO READ: Medicine price display rule to stay
However, Lukanisman noted that the ministry remains committed to inclusive engagement with stakeholders, including the Malaysian Medical Association, to address these issues and ensure a balanced approach to healthcare regulation.
Addressing concerns raised by Jimmy Puah Wee Tse (PH-Tebrau) about rising medical costs, Lukanisman highlighted the ministry's ongoing efforts to implement interim Diagnosis-Related Group (DRG) systems in private facilities by 2027.
"The DRG data will guide private facilities in setting reasonable prices, although it won't regulate profit margins," he said.
DRG systems classify hospital cases with similar clinical characteristics and resource usage, allowing for a standardised payment system based on the diagnosis and treatment provided.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
15 hours ago
- The Star
Five deaths linked to vape use
A TOTAL of five deaths linked to the use of e-cigarettes or vapes were reported between 2019 and June 2025, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. He said his ministry received a total of 83 reported cases of diseases linked to the use of smoking products, including e-cigarettes or vapes, as of June 2025. 'Of these, 44 cases involved serious complications affecting the lungs, while the remaining 39 cases involved other health complications not directly related to the lungs. 'Although there have been deaths involving individuals who used e-cigarettes or vape, a direct causal link between vape use and the cause of death is difficult to confirm, due to limited clinical evidence and other contributing factors,' he said in a written reply to Wan Razali Wan Nor (PN-Kuantan). Wan Razali wanted the Health Ministry to reveal the number of deaths related to the use of e-cigarettes and vapes. He also asked the ministry to explain its efforts to curb the use of e-cigarettes and vapes among children and teenagers. Dr Dzulkefly said the ministry is currently strengthening surveillance to identify the causes of deaths associated with smoking products. This effort, he added, is in line with the implementation of Section 21 of the Control of Smoking Products for Public Health Act 2024, which gives the minister the authority to ban or restrict the import, manufacturing, distribution, or sale of smoking products, based on the recommendations of a committee established under that section. He also said that in 2024, a total of 230 primary school pupils were found to have smoking problems and 193 of them have undergone smoking cessation interventions. For secondary school students, 44,211 were identified to have smoking problems and 36,870 have undergone interventions, he said. To curb e-cigarette and vape use among children and teenagers, the ministry has taken several measures, including enforcing regulations under the Control of Smoking Products for Public Health Act 2024 to protect them from being exposed to and influenced by smoking habits, said Dr Dzulkefly. 'The ministry is also implementing a strict prohibition on the sale and purchase of all smoking products, including electronic cigarettes and vapes, especially to those who are underaged,' he added. In addition, the ministry also implemented prevention and smoking cessation intervention programmes for school students through the Oral Health Without Smoking Practice Program. He said smoking cessation services are also provided through 857 Quit Smoking Clinics and 111 One Stop Centres for Addiction across the country. 'Parents or guardians can bring children who are involved in smoking or using electronic cigarettes or vapes to these clinics to get professional treatment and cessation support,' he said.
The Sun
16 hours ago
- The Sun
Vape deaths under scrutiny, govt steps up crackdown
PETALING JAYA: The Health Ministry has recorded five deaths likely linked to electronic cigarettes or vapes from 2019 to June this year. In a written reply to Parliament, it said 83 reports of illnesses related to smoking products, including vapes, were received during the period, comprising 44 cases of serious lung complications and 39 involving other health problems. 'While some deaths have involved vape users, establishing a direct causal link remains difficult due to limited clinical evidence and other contributing factors,' it said. The ministry said it is enhancing its surveillance system to pinpoint the causes of vape-related deaths, in line with the Control of Smoking Products for Public Health Act 2024 (Act 852). The law empowers the minister to restrict or ban the import, manufacture, distribution or sale of smoking products based on expert committee recommendations. To curb vaping among minors, the ministry is enforcing Act 852 provisions, including a ban on the sale and purchase of smoking products by those under 18. 'As of June, 27 offence notices have been issued, amounting to RM1,350 in compounds. Additionally, the use of such products by minors is prohibited, with 2,619 notices issued, totalling RM130,950 in compounds,' it said. Strict advertising bans have led to 340 investigations, while restrictions on sales in schools, online platforms, vending machines, vape trucks and markets have triggered 45 cases to curb minors' access. 'Furthermore, there is a ban on disposable vape pods resembling toys or food items, which have prompted 51 investigations. These combined efforts reflect the government's commitment to prevent youths from engaging in vaping and protecting public health,' the ministry said. On Aug 4, theSun reported that vape liquids containing a dangerous synthetic substance dubbed 'magic mushroom' were being sold via online platforms. The ministry said school-based prevention and cessation programmes are also being rolled out. This year, 230 primary pupils and 44,211 secondary students were identified as smokers, with most receiving cessation interventions. It added that collaboration with the Education and Higher Education ministries has reinforced bans on students carrying vapes, while over 12,500 teachers have been trained to conduct anti-smoking programmes. 'Across the country, 857 quit smoking clinics and 111 one-stop-centres for addiction offer professional support to those seeking to quit.' The ministry said it is also working on community advocacy with NGOs, including the Malaysian Drug Prevention Association, National Cancer Society Malaysia, Islamic Medical Association of Malaysia and Parents Against Smoking and Vaping Association. 'The involvement of all parties reflects a 'whole of society' approach towards a smoke-free Malaysia by 2040.'
The Star
19 hours ago
- The Star
DRG model still challenging for private healthcare
Unlike the conventional fee-for-service model, the DRG system sets a fixed price for treatments based on case complexity and industry benchmarks. PETALING JAYA: Malaysia's diagnosis related group (DRG) model to manage rising healthcare costs and allocate medical resources remains a challenge for implementation in private hospitals, analysts say. This is despite efforts to find solutions, including data collection. The issue is compounded by absence of a universal healthcare financing system in Malaysia. Unlike the conventional fee-for-service model, the DRG system sets a fixed price for treatments based on case complexity and industry benchmarks. According to Bank Negara data, medical inflation in the country reached 15% last year compared with the global average of 10% and the Asia Pacific average of 11%. For insurers, this becomes a problem as claims rose by 73% between 2021 and 2023 while premiums collected only increased by 21%. CIMB Research, who spoke to Association of Private Hospitals Malaysia (APHM) president Datuk Dr Kuljit Singh, said implementation of the DRG model in private hospitals could be challenging due to the absence of a universal healthcare financing framework and limited data availability despite efforts focused on generating and collecting data. The research house, quoting Kuljit, noted that no robust DRG models exist globally for private healthcare except in cases involving a single funder or universal healthcare financing. Public hospitals have all come under a mix of the DRG model and annual budgets to fund and provide for healthcare. 'Most countries use DRG in public healthcare to calculate costs and determine government budgets. In private settings, challenges emerge when patients face complications or require additional care beyond what the system covers,' the research house said, adding that the lack of data accuracy makes an effective rollout of the DRG model challenging for private hospitals. Despite the challenges, Kuljit shared that APHM-affiliated hospitals have been working closely with the Health Ministry and holding regular engagements to support an effective rollout of the DRG model. CIMB Research has maintained an 'overweight' stance on healthcare stocks, underpinned by the defensive nature of such stocks and the demand for private healthcare. Growth prospects remain supported by organic expansion, the rising prevalence of non-communicable diseases and an ageing population. IHH Healthcare Bhd remains the research house's top pick with a 'buy' call and target price of RM8.50. It has a 'hold' rating on KPJ Healthcare Bhd with a target price of RM2.90. 'Within our coverage, we believe KPJ is more exposed to risks from the possible implementation of DRG in Malaysia, given that 98.1% of its revenue for the first quarter for this year (1Q25) was derived locally. 'In comparison, we estimate Malaysian operations contributed only 18% to 21% of IHH's 1Q25 revenue,' the research house said. IHH has a presence across Malaysia, Singapore, Turkiye, Europe and India.
